Signet Therapeutics Company
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Headquarters:
Newton, Massachusetts, United States
Industry:
Early and Preclinical Drug Development
Investors Number:
5
Funding Status:
Seed
Last Funding Type:
Seed
Founded Date:
2020-01-01
Total Funding:
20000000
Last Funding Date:
2021-10-29